relates with prostate cancer skeletal progression; however, the impact of prostate cancer-derived PTHrP on the microenviron-ment and osteoblastic lesions in skeletal metastasis has not been completely elucidated. In this study, PTHrP overexpressing pros-tate cancer clones were stably established by transfection of full length rat PTHrP cDNA. Expression and secretion of PTHrP were verified by western blotting and IRMA assay. PTHrP over-expressing prostate cancer cells had higher growth rates in vitro, and generated larger tumors when inoculated subcutaneously into athymic mice. The impact of tumor-derived PTHrP on bone was investigated using a vossicle co-implant model. Histology revealed increased bone mass adjacent to PTHrP overexpressing ...
In this study, we have used a well-validated breast cancer animal model to examine the malignant pro...
The study included in this thesis was aimed at elucidating the mechanisms involved in the actions of...
Background:Up to 80% of patients dying from prostate carcinoma have developed bone metastases that a...
Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental f...
Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental f...
<p>A) X-ray and uCT Images showing the effect of PTHrP overexpression on bone destruction in an intr...
Prostate cancer (PCa) preferentially metastasizes to bone resulting in osteoblastic lesions with und...
Bone metastasis is the most devastating and untreatable complication associated with prostate cancer...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Skeletal metastasis is a lethal component of many advanced cancers including prostate, the second mo...
Our study aimed at understanding the regulation of parathyroid hormone related peptide (PTHRP) by an...
Giant Cell Tumor of Bone (GCT) is an aggressive skeletal tumor characterized by local bone destructi...
Osteosarcoma (OS) is the most common cancer of bone. Parathyroid hormone (PTH) regulates calcium hom...
Bony metastases from prostate cancer are a significant cause of morbidity and mortality. These metas...
In this study, we have used a well-validated breast cancer animal model to examine the malignant pro...
The study included in this thesis was aimed at elucidating the mechanisms involved in the actions of...
Background:Up to 80% of patients dying from prostate carcinoma have developed bone metastases that a...
Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental f...
Parathyroid hormone-related protein (PTHrP) possesses a variety of physiological and developmental f...
<p>A) X-ray and uCT Images showing the effect of PTHrP overexpression on bone destruction in an intr...
Prostate cancer (PCa) preferentially metastasizes to bone resulting in osteoblastic lesions with und...
Bone metastasis is the most devastating and untreatable complication associated with prostate cancer...
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that th...
Patients with advanced prostate cancer often develop bone metastases, leading to bone pain, skeletal...
Skeletal metastasis is a lethal component of many advanced cancers including prostate, the second mo...
Our study aimed at understanding the regulation of parathyroid hormone related peptide (PTHRP) by an...
Giant Cell Tumor of Bone (GCT) is an aggressive skeletal tumor characterized by local bone destructi...
Osteosarcoma (OS) is the most common cancer of bone. Parathyroid hormone (PTH) regulates calcium hom...
Bony metastases from prostate cancer are a significant cause of morbidity and mortality. These metas...
In this study, we have used a well-validated breast cancer animal model to examine the malignant pro...
The study included in this thesis was aimed at elucidating the mechanisms involved in the actions of...
Background:Up to 80% of patients dying from prostate carcinoma have developed bone metastases that a...